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EDITORIAL
The adolescent tuberculosis care cascade: an urgent need to 
address high rates of loss to follow-up from diagnosis to cure
Palwasha Y. Khan1,2
Adolescence and early adult life presents a period of heightened risk during the life course with re-
spect to the acquisition of a new tuberculous infection 
and subsequent progression to tuberculosis.1 Tubercu-
losis in this age group is also more likely to be infec-
tious than in children, and as such, adolescents and 
young adults are considered an at-risk group for on-
ward tuberculosis transmission in the community.
Although the importance of the adolescent age 
group in human immunodeficiency virus (HIV) con-
trol is increasingly appreciated, tuberculosis among 
adolescents has been neglected to date.2 This is chang-
ing, however, and tuberculosis in adolescence has re-
cently been recognised as a priority on the adolescent 
health research agenda.3 The paucity of data on the 
burden of disease in this overlooked population has 
also been exacerbated by the nature of programmatic 
reporting, which splits the group between children 
(age 0–14 years) and adults (age 15 years).4
Due to the demographic structure of many 
high-burden settings,5 adolescents and young adults 
represent a significant proportion of patients who ini-
tiate anti-tuberculosis treatment,6 and thus improving 
the treatment outcomes in this demographic group is 
of great importance to global tuberculosis control.7 
However, assessment of the quality of tuberculosis 
care provided to patients has received very little atten-
tion, apart from a few exceptions,8 with national tu-
berculosis programmes more focused on improving 
‘coverage’, such as increasing the availability of free 
tuberculosis diagnostic and treatment services.9 This is 
in stark contrast to the HIV community, which has ex-
tensively used cascade of care analyses to assess the 
quality of care and identify and address major defi-
ciencies in the continuum of care from diagnosis 
through to effective treatment for many years.10
In this issue of Public Health Action, Reif et al. 
adopt the cascade of care model to evaluate the tu-
berculosis care continuum among adolescents and 
young adults (aged 10–24 years) with microbiologi-
cally confirmed tuberculosis, in a specialist adoles-
cent clinic providing integrated HIV and tuberculo-
sis care in Port-au-Prince, Haiti.11 The paper 
highlights the poor treatment outcomes in this 
high-risk population and addresses a critical gap in 
the TB literature. Importantly, it emphasises the vul-
nerability of adolescents with tuberculosis, with and 
without HIV co-infection, even in a clinical setting 
with enhanced clinical support services. The study 
captured critical data on the care cascade prior to 
initiation of TB treatment, which is rarely reported. 
They found that this initial step of the care cascade 
was where the largest loss of adolescents with micro-
biologically confirmed tuberculosis, and therefore 
potentially infectious tuberculosis, occurred. How-
ever, it appears that providing same-day TB treat-
ment initiation within the clinic may mitigate this 
loss, although this finding needs to be replicated in 
other settings. Worryingly, the outcomes were worse 
for HIV-positive than HIV-negative adolescents at 
each step of the continuum, despite a dedicated ado-
lescent clinic setting providing a youth-friendly ser-
vice with social support programmes, including 
HIV-positive peer educators, transportation vouchers 
and tracking patients who had missed clinic ap-
pointments. Older adolescents and young adults 
were more likely than younger adolescents to be lost 
from care after treatment initiation—a finding repli-
cated within HIV care.12
As noted by the authors, the data are limited by the 
lack of information on the reasons for loss to fol-
low-up, which would help to inform clinic- or even 
community-based interventions to facilitate engaging 
adolescents and young adults in TB care. However, this 
sub-population cascade does highlight the need for the 
TB community to improve and tailor services and 
counteract the period of biological and psychosocial 
vulnerability for this vulnerable, high-risk population.
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